Amaury Vigneau, Thomas Batard, Maximilien Delay, Maxime Chabenes, Amélie Bazinet, Thibaud Garnier, Gaelle Fiard, Clement Sarrazin
{"title":"膀胱切除术和回肠导管治疗神经源性下尿路功能障碍:不同手术方式的系统回顾。","authors":"Amaury Vigneau, Thomas Batard, Maximilien Delay, Maxime Chabenes, Amélie Bazinet, Thibaud Garnier, Gaelle Fiard, Clement Sarrazin","doi":"10.1016/j.urology.2025.06.041","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess the outcomes of cystectomy and ileal conduit for managing neurogenic lower urinary tract dysfunction and compare different surgical approaches (open, laparoscopic, and robotic-assisted).</p><p><strong>Design, setting, and participants: </strong>This systematic review was conducted in accordance with PRISMA guidelines, and the protocol was registered in the PROSPERO database (CRD42024512893). A systematic search of MEDLINE/PubMed, Embase, and CENTRAL identified original articles reporting surgical outcomes of cystectomy and ileal conduit in adult neuro-urological patients. Our primary outcome was 30-day high-grade complications. Secondary outcomes included perioperative parameters, late complications, quality of life, and kidney function.</p><p><strong>Results and limitations: </strong>Ten studies with a high risk of bias were included, comprising 721 patients. Minimally invasive approaches had longer operative times. Mean blood loss was 872 ± 325 mL for open, 376 ± 62 mL for laparoscopic, and 291 ± 29 mL for robotic-assisted approach. Reported hospital stay durations varied (open: 21 ± 3.3 days; laparoscopic: 17 ± 5.8 days; robotic-assisted: 13 ± 1.9 days). Early complication rates were similar across approaches (15-20% for high-grade complications). Late high-grade complication rates ranged from 19% to 26%. Studies reported improved postoperative quality of life and generally stable kidney function, though assessment methods varied considerably.</p><p><strong>Conclusion: </strong>Cystectomy with ileal conduit in NLUTD patients is associated with substantial complication rates across all surgical methods. The available evidence is heterogeneous and subject to significant confounding factors. Differences observed between surgical approaches should be interpreted with caution. Prospective comparative studies with standardized reporting are needed to determine the optimal surgical approach for this specific patient population.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cystectomy and Ileal Conduit for Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review of Outcomes for Different Surgical Approaches.\",\"authors\":\"Amaury Vigneau, Thomas Batard, Maximilien Delay, Maxime Chabenes, Amélie Bazinet, Thibaud Garnier, Gaelle Fiard, Clement Sarrazin\",\"doi\":\"10.1016/j.urology.2025.06.041\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To assess the outcomes of cystectomy and ileal conduit for managing neurogenic lower urinary tract dysfunction and compare different surgical approaches (open, laparoscopic, and robotic-assisted).</p><p><strong>Design, setting, and participants: </strong>This systematic review was conducted in accordance with PRISMA guidelines, and the protocol was registered in the PROSPERO database (CRD42024512893). A systematic search of MEDLINE/PubMed, Embase, and CENTRAL identified original articles reporting surgical outcomes of cystectomy and ileal conduit in adult neuro-urological patients. Our primary outcome was 30-day high-grade complications. Secondary outcomes included perioperative parameters, late complications, quality of life, and kidney function.</p><p><strong>Results and limitations: </strong>Ten studies with a high risk of bias were included, comprising 721 patients. Minimally invasive approaches had longer operative times. Mean blood loss was 872 ± 325 mL for open, 376 ± 62 mL for laparoscopic, and 291 ± 29 mL for robotic-assisted approach. Reported hospital stay durations varied (open: 21 ± 3.3 days; laparoscopic: 17 ± 5.8 days; robotic-assisted: 13 ± 1.9 days). Early complication rates were similar across approaches (15-20% for high-grade complications). Late high-grade complication rates ranged from 19% to 26%. Studies reported improved postoperative quality of life and generally stable kidney function, though assessment methods varied considerably.</p><p><strong>Conclusion: </strong>Cystectomy with ileal conduit in NLUTD patients is associated with substantial complication rates across all surgical methods. The available evidence is heterogeneous and subject to significant confounding factors. Differences observed between surgical approaches should be interpreted with caution. Prospective comparative studies with standardized reporting are needed to determine the optimal surgical approach for this specific patient population.</p>\",\"PeriodicalId\":23415,\"journal\":{\"name\":\"Urology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2025-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.urology.2025.06.041\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urology.2025.06.041","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Cystectomy and Ileal Conduit for Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review of Outcomes for Different Surgical Approaches.
Objective: To assess the outcomes of cystectomy and ileal conduit for managing neurogenic lower urinary tract dysfunction and compare different surgical approaches (open, laparoscopic, and robotic-assisted).
Design, setting, and participants: This systematic review was conducted in accordance with PRISMA guidelines, and the protocol was registered in the PROSPERO database (CRD42024512893). A systematic search of MEDLINE/PubMed, Embase, and CENTRAL identified original articles reporting surgical outcomes of cystectomy and ileal conduit in adult neuro-urological patients. Our primary outcome was 30-day high-grade complications. Secondary outcomes included perioperative parameters, late complications, quality of life, and kidney function.
Results and limitations: Ten studies with a high risk of bias were included, comprising 721 patients. Minimally invasive approaches had longer operative times. Mean blood loss was 872 ± 325 mL for open, 376 ± 62 mL for laparoscopic, and 291 ± 29 mL for robotic-assisted approach. Reported hospital stay durations varied (open: 21 ± 3.3 days; laparoscopic: 17 ± 5.8 days; robotic-assisted: 13 ± 1.9 days). Early complication rates were similar across approaches (15-20% for high-grade complications). Late high-grade complication rates ranged from 19% to 26%. Studies reported improved postoperative quality of life and generally stable kidney function, though assessment methods varied considerably.
Conclusion: Cystectomy with ileal conduit in NLUTD patients is associated with substantial complication rates across all surgical methods. The available evidence is heterogeneous and subject to significant confounding factors. Differences observed between surgical approaches should be interpreted with caution. Prospective comparative studies with standardized reporting are needed to determine the optimal surgical approach for this specific patient population.
期刊介绍:
Urology is a monthly, peer–reviewed journal primarily for urologists, residents, interns, nephrologists, and other specialists interested in urology
The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon''s workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.